Literature DB >> 9868655

Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man.

A Jahangir1, C Kolbert, W Edwards, P Mitchell, J S Dumler, D H Persing.   

Abstract

Human cases of infection with a granulocytotropic Ehrlichia species closely related to Ehrlichia equi are now being described with increasing frequency in the United States, especially in areas where Lyme disease is already endemic. We describe a case of fatal pancarditis during the course of human granulocytic ehrlichiosis (HGE) in a 44-year-old outdoor worker who was previously treated for presumptive Lyme disease. Serological and molecular diagnostic tests for Borrelia burgdorferi and Babesia microti infections were negative. Postmortem serum specimens were seroreactive for HGE, and molecular evidence of infection with the HGE agent was obtained. These findings suggest that carditis may be a manifestation of HGE, further complicating the differential diagnosis of tick-borne illness.

Entities:  

Mesh:

Year:  1998        PMID: 9868655     DOI: 10.1086/515014

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Serological evidence for human granulocytic ehrlichiosis in Western Austria.

Authors:  G Walder; G Tiwald; M P Dierich; R Würzner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

Review 2.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.

Authors:  Y F Chang; S P McDonough; C F Chang; K S Shin; W Yen; T Divers
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with or without coronary stenosis.

Authors:  C Stöllberger; G Mölzer; J Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

6.  Molecular typing of the etiologic agent of human granulocytic ehrlichiosis.

Authors:  S E Carter; M D Ravyn; Y Xu; R C Johnson
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Human granulocytic anaplasmosis affecting the myocardium.

Authors:  Amyn Malik; Mohammad NurulQadr Jameel; Syed Sohail Ali; Sajad Mir
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

8.  Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.

Authors:  M Akkoyunlu; S E Malawista; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila.

Authors:  Hyung-Yong Kim; Jason Mott; Ning Zhi; Tomoko Tajima; Yasuko Rikihisa
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 10.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.